$SER insider trading
Over the last 12 months, Serina Therapeutics insiders reported 4 buys totaling $39K and 25 sales totaling $1K across SEC Form 4 filings. 86% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- $39K 4 events
- Sold · 12m
- $1K 25 events
- Events · 12m
- 29 Form 4 filings, grouped
- Insiders · 12m
- 4 distinct reporters
- 10b5-1 share
- 86% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Brannan Stephen K.D | ▲ Buy | 1,000 | $2.03 | $2K | — | — |
| Jun 12, 2026 | WILSON KAREN JD | ▲ Buy | 10,100 | $1.76 | $18K | — | 2 tranches |
| May 22, 2026 | Venkatesan JayD | ▲ Buy | 589 | $1.78 | $1K | — | late |
| May 21, 2026 | WILSON KAREN JD | ▲ Buy | 10,000 | $1.77 | $18K | — | — |
| Mar 23, 2026 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 6,500 | — | — | -100% | plan |
| Mar 19, 2026 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 39,000 | — | — | -100% | plan |
| Feb 2, 2026 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 6,500 | — | — | -100% | plan |
| Jan 28, 2026 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 6,500 | — | — | -100% | plan |
| Jan 22, 2026 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 2,500 | — | — | -100% | plan |
| Jan 21, 2026 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 4,000 | — | — | -100% | plan · 2 tranches |
| Jan 14, 2026 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 6,500 | — | — | -100% | plan · 2 tranches |
| Jan 8, 2026 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 13,000 | — | — | -100% | plan |
| Dec 23, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 4,100 | — | — | -100% | plan · late |
| Dec 22, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 5,673 | — | — | -100% | plan |
| Dec 16, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 3,227 | — | — | -100% | plan |
| Dec 12, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 1,700 | — | — | -100% | plan |
| Dec 11, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 3,555 | — | — | -100% | plan |
| Dec 10, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 1,245 | — | — | -100% | plan · 2 tranches |
| Dec 3, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 6,500 | — | — | -100% | plan · 2 tranches |
| Nov 25, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 5,965 | — | — | -50% | plan |
| Nov 24, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 535 | — | — | -100% | plan |
| Nov 18, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 6,500 | — | — | -100% | plan |
| Nov 10, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 6,500 | — | — | -100% | plan |
| Nov 5, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 3,398 | $0.04 | $144 | -100% | plan |
| Nov 4, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 3,102 | $0.04 | $136 | -100% | plan |
| Oct 28, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 5,551 | $0.05 | $275 | -100% | plan |
| Oct 27, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 949 | $0.05 | $49 | -100% | plan |
| Oct 20, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 6,500 | $0.05 | $323 | -100% | plan |
| Oct 13, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 4,326 | $0.05 | $225 | -100% | plan |
| Aug 26, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 47,674 | $0.06 | $115 | -100% | plan · 2 tranches |
| Aug 20, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 4,304 | $0.05 | $223 | -100% | plan · 2 tranches |
| Aug 12, 2025 | Moreadith RandallChief Scientific Officer · O | ▼ Sale | 5,500 | $0.05 | $289 | -100% | plan |
Every $SER filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Serina Therapeutics filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $SER feed.